34-51-2. Eligible patient defined.
For the purposes of this chapter, the term, eligible patient, means a patient who meets all the following qualifications:
(1)Has an advanced illness, attested by the patient's treating physician;
(2)Has considered all other treatment options currently approved by the United States Food and Drug Administration;
(3)Has received a recommendation from the patient's treating physician for an investigational drug, biological product, or device;
(4)Has given written, informed consent for the use of the investigational drug, biological product, or device; and
(5)Has documentation from the patient's treating physician that the patient meets requirements pursuant to this chapter.
Source: SL 2015, ch 188, §2.